Dr. Christopher U. Rex, M.D.
Dermatology (Dermatology Physician)
127 E Main St Ste A
Payson, AZ 85541
Who else practices at this address →
Gila County includes primary care (47% of residents) and dental (11% of residents) and mental health (96% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Albert Einstein College of Medicine of Yeshiva University (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 2,560
Licensed in California since 2017, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: Albert Einstein College of Medicine of Yeshiva University
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
AZ license 56105 -
Internal Medicine Physician
PA license MT204558 -
MOHS-Micrographic Surgery Physician
CA license A148673 (first issued 2017; current) -
Pediatric Dermatology Physician
AZ license 56105 · CA license A148673 (first issued 2017; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Kaweah Health Medical Center Visalia, CA
- Banner PAyson Medical Center Payson, AZ
Medical groups
- Dermatology Spa Med Inc (8 clinicians)
- Innovative Dermatology Alliance Ca (7 clinicians)
- Arizona Institute of Dermatology PAyson LLC (4 clinicians)
- Peak Health Medical Group LLC (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,560
- Services billed
- 215,759
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 45,501 | 128 |
| Destruction of precancer skin growth, 2-14 growths | 2,429 | 485 |
| Established patient office or other outpatient visit, 20-29 minutes | 930 | 690 |
| Destruction of precancer skin growth, 1 growth | 839 | 652 |
| New patient office or other outpatient visit, 30-44 minutes | 835 | 835 |
| Biopsy of related skin growth, first growth | 598 | 535 |
| Destruction of skin growth, 1-14 growths | 548 | 463 |
| Dermacyte amniotic membrane allograft, per square centimeter | 276 | 18 |
| Biopsy of related skin growth, each additional growth | 256 | 178 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 215 | 189 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 50 payments worth $1,776 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $1,041 |
|---|---|
| AbbVie Inc. | $150 |
| Biofrontera Inc. | $91.79 |
| Sun Pharmaceutical Industries Inc. | $90.78 |
| Strata Skin Sciences, Inc. | $65.57 |
| Janssen Biotech, Inc. | $48.26 |
| Surgenex LLC | $41.04 |
| Pfizer Inc. | $35.43 |
| Food and Beverage | $1,154 |
|---|---|
| Travel and Lodging | $622 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation Sep 26, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Chicago, IL · in-kind | $424 |
| Novartis Pharmaceuticals Corporation Sep 26, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Chicago, IL · in-kind | $198 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $12,238 in research payments for these studies, mostly to the institutions running them.
- A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
AbbVie Inc. · Active, not recruiting · NCT05889182 - A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Contro…
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.